- Home
- MTZ vs BNTX Comparison
MTZ vs BNTX Comparison
Compare MTZ & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTZ | BNTX |
|---|---|---|
| Founded | 1929 | 2008 |
| Country | United States | Germany |
| Employees | 36000 | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.9B | 22.8B |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MTZ | BNTX |
|---|---|---|
| Price | $315.16 | $85.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 19 | 13 |
| Target Price | ★ $285.78 | $134.15 |
| AVG Volume (30 Days) | 948.9K | ★ 1.3M |
| Earning Date | 04-30-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.12 | N/A |
| EPS | ★ 5.07 | N/A |
| Revenue | ★ $14,299,171,000.00 | N/A |
| Revenue This Year | $20.38 | N/A |
| Revenue Next Year | $10.02 | $4.76 |
| P/E Ratio | $60.38 | ★ N/A |
| Revenue Growth | ★ 16.22 | N/A |
| 52 Week Low | $99.70 | $79.81 |
| 52 Week High | $328.69 | $124.00 |
Technical Indicators
Market Signals| Indicator | MTZ | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 59.17 | 33.71 |
| Support Level | $166.03 | $79.81 |
| Resistance Level | N/A | $113.12 |
| Average True Range (ATR) | 12.34 | 2.69 |
| MACD | -0.34 | -0.31 |
| Stochastic Oscillator | 66.02 | 34.83 |
Price Performance
Historical ComparisonAbout MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; pipeline infrastructure; power delivery; and other.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.